Safety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy
- DOI
- 10.1007/s10157-026-02972-0
- Published
- 2026-10-17
- Container
- Clinical and Experimental Nephrology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10157-026-02972-0,
title = {Safety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy},
author = {Yuko Shima and Hironobu Mukaiyama and Yu Tanaka and Wataru Shimabukuro and Hiroshi Kaito and Ryojiro Tanaka and Kandai Nozu and Kazumoto Iijima and Daisuke Tokuhara and Norishige Yoshikawa and Koichi Nakanishi},
year = {2026},
journal = {Clinical and Experimental Nephrology},
doi = {10.1007/s10157-026-02972-0},
url = {https://doi.org/10.1007/s10157-026-02972-0}
}RIS
TY - JOUR TI - Safety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy AU - Yuko Shima AU - Hironobu Mukaiyama AU - Yu Tanaka AU - Wataru Shimabukuro AU - Hiroshi Kaito AU - Ryojiro Tanaka AU - Kandai Nozu AU - Kazumoto Iijima AU - Daisuke Tokuhara AU - Norishige Yoshikawa AU - Koichi Nakanishi PY - 2026 JO - Clinical and Experimental Nephrology DO - 10.1007/s10157-026-02972-0 UR - https://doi.org/10.1007/s10157-026-02972-0 ER -
APA
Shima, Y., Mukaiyama, H., Tanaka, Y., Shimabukuro, W., Kaito, H., Tanaka, R., Nozu, K., Iijima, K., Tokuhara, D., Yoshikawa, N., & Nakanishi, K. (2026). Safety and efficacy of prednisolone, mizoribine and lisinopril combination therapy for severe childhood IgA nephropathy. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-026-02972-0
Source records
- crossref · retrieved 2026-11-10T16:29:34.381Z